tyrosine has been researched along with Arterial Occlusive Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W; Lei, B; Li, F; Li, H; Liu, W; Nogueira, RG; Qiu, Z; Sang, H; Saver, JL; Yang, Q; Zhang, M; Zhou, P; Zhou, Z; Zi, W | 1 |
| Ballotta, E; Baracchini, C; Causin, F; Cester, G; Farina, F; Favaretto, S; Kulyk, C; Nico, L; Palmieri, A; Soso, M; Viaro, F | 1 |
| Glahn, J; Philipps, J; Rother, J; Schwarze, M; Thomalla, G | 1 |
| Juhász, L; Kaszaki, J; Kiss, A; Kovács, M; Nyeso, E; Seprényi, G; Végh, A | 1 |
| Erkoc, R; Eryonucu, B; Tuncer, M | 1 |
| Caputi, AP; Ciliberto, G; Costantino, G; Cuzzocrea, S; De Sarro, A; De Sarro, G; Mazzon, E | 1 |
| Barberi, I; Caputi, AP; Cordaro, S; Costantino, G; Cucinotta, G; Cuzzocrea, S; De Sarro, A; Fulia, F; Gitto, E; Mazzon, E; McDonald, MC; Siriwardena, D; Thiemermann, C | 1 |
| Aston, K; Caputi, AP; Cuzzocrea, S; Dugo, L; Mazzon, E; Riley, DP; Salvemini, D | 1 |
| Goto, S; Handa, M; Ikeda, Y; Murata, M | 1 |
| Cucchiara, BL; Hurst, RW; Liebeskind, DS; McGarvey, ML; Pollard, JR; Schwartz, ED | 1 |
1 review(s) available for tyrosine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
A new approach to antiplatelet therapy: inhibitor of GPIb/V/IX-vWF interaction.
Topics: Acetates; Adenosine Diphosphate; Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Collagen; Drug Evaluation, Preclinical; Epinephrine; Epitopes; Genetic Predisposition to Disease; Guinea Pigs; Hemorheology; Humans; Integrins; Liposomes; Macromolecular Substances; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Genetic; Receptors, Collagen; Recombinant Fusion Proteins; Stress, Mechanical; Thrombosis; Tyrosine; von Willebrand Factor | 2000 |
2 trial(s) available for tyrosine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Endovascular treatment with versus without tirofiban for stroke patients with large vessel occlusion: The multicenter, randomized, placebo-controlled, double-blind RESCUE BT study protocol.
Topics: Arterial Occlusive Diseases; Double-Blind Method; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2022 |
Treatment of progressive stroke with tirofiban--experience in 35 patients.
Topics: Aged; Arterial Occlusive Diseases; Disease Progression; Female; Humans; Injections, Intravenous; Male; Microcirculation; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
7 other study(ies) available for tyrosine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Stentriever Thrombectomy Failure: A Challenge in Stroke Management.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebral Angiography; Computed Tomography Angiography; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Intracranial Hemorrhages; Magnetic Resonance Angiography; Male; Middle Aged; Mortality; Prospective Studies; Stents; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Treatment Outcome; Tyrosine; Ultrasonography, Doppler, Transcranial | 2017 |
Is there a trigger role of peroxynitrite in the anti-arrhythmic effect of ischaemic preconditioning and peroxynitrite infusion?
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Coronary Vessels; Dogs; Female; Heart Ventricles; Hemodynamics; Hydrogen-Ion Concentration; Infusions, Intra-Arterial; Ischemic Preconditioning, Myocardial; Male; Myocardial Reperfusion Injury; Nitrates; Nitrites; Peroxynitrous Acid; Superoxides; Time Factors; Tyrosine; Uric Acid | 2011 |
Repetitive profound thrombocytopenia after treatment with tirofiban: a case report.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Administration Schedule; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombocytopenia; Ticlopidine; Tirofiban; Tyrosine | 2004 |
IL-6 knock-out mice exhibit resistance to splanchnic artery occlusion shock.
Topics: Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Celiac Artery; Constriction; Cytokines; Ileum; Immunity, Innate; Intercellular Adhesion Molecule-1; Interleukin-6; Ischemia; Leukocyte Count; Lipid Peroxidation; Malondialdehyde; Mesenteric Artery, Superior; Mice; Mice, Knockout; Neutrophils; Nitrates; Nitric Oxide; P-Selectin; Peroxidase; Reperfusion Injury; Shock; Splanchnic Circulation; Tyrosine | 1999 |
Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury.
Topics: Animals; Arterial Occlusive Diseases; Brain; Brain Edema; Cerebral Arteries; Cyclic N-Oxides; Free Radical Scavengers; Gerbillinae; Hippocampus; Lipid Peroxides; Male; Malondialdehyde; Motor Activity; Neutrophil Infiltration; Nitrates; Nitrites; Peroxidase; Poly(ADP-ribose) Polymerases; Reperfusion Injury; Spin Labels; Survival Analysis; Tyrosine | 2000 |
Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arterial Occlusive Diseases; Catalysis; Cytokines; Fluorescent Antibody Technique; Ileum; Leukocyte Count; Male; Malondialdehyde; Manganese; Nitrates; Nitrites; Organometallic Compounds; P-Selectin; Peroxidase; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Splanchnic Circulation; Superoxide Dismutase; Superoxides; Tyrosine | 2001 |
Vertebrobasilar thrombolysis with intravenous tirofiban: case report.
Topics: Aged; Arterial Occlusive Diseases; Fibrinolytic Agents; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine; Vertebrobasilar Insufficiency | 2002 |